CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Total Assets Change 1.41 % 5.43 % 8.57 % 9.5 % -3.64 %
Y / Y Net Income Change -9.81 % -5.17 % 2.69 % -17.26 % -8.38 %
Net Income (TTM) in Millions 7,085 7,264 7,352 7,299 7,675
Return On Assets (TTM) 11.11 % 11.43 % 11.72 % 11.87 % 12.78 %
Total Ranking # 502 # 419 # 363 # 334 # 340
Total Assets (TTM) in Millions 62,539 62,948 64,637 65,011 61,669
Seq. Total Assets Change -0.65 % -2.61 % -0.58 % 5.42 % 3.29 %
Seq. Net Income Change 1.92 % -20.09 % 12.09 % -1.21 % 7.16 %


Roa Comment
Amgen Inc yielded Return on Asset in I. Quarter above company average, at 11.11 %.

ROA detoriated compare to previous period, despite net income growth.

Within Healthcare sector 83 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 419 to 502.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 18
Sector # 84
Overall # 502

Return On Assets Statistics
High Average Low
12.98 %
9.76 %
2.49 %
(March 31, 2006)   (Dec 31 2017)


Financial Statements
Amgen Inc 's Assets $ 62,539 Millions AMGN's Balance sheet
Amgen Inc 's Income $ 1,646 Millions Quarterly AMGN's Income Statement
AMGN's Income by Division See AMGN's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
Y / Y Total Assets Change 5.43 % -10.1 % -16.93 % 3 % 8.45 %
Total Assets in Millions 62,948 59,707 66,416 79,954 77,626
Y / Y Net Income Change -7.37 % -6.58 % 324.15 % -74.37 % 11.28 %
Net Income in Millions 7,264 7,842 8,394 1,979 7,722
Return On Assets 11.54 % 13.13 % 12.64 % 2.48 % 9.95 %




Roa Comment
In the fiscal year 2020 Amgen Inc 's ROA decreased compare to previous year to 11.54 %, due to detoriation of net income -7.37 % to $7,264.00 millions, from $7,842.00 millions a year ago, as AMGN's assets were $62,948.00 millions.


More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMGN's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for AMGN's Competitors
Roa for Amgen Inc 's Suppliers
Return On Asstes for AMGN's Customers

You may also want to know
AMGN's Roi AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons
AMGN's Annual Roi AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2021, within Healthcare Sector ROA
Ironwood Pharmaceuticals inc   27.26 %
Bionexus Gene Lab Corp  26.82 %
National Research Corporation  26.50 %
Hologic Inc  25.71 %
Viemed Healthcare Inc   25.65 %
Lakeland Industries Inc  25.17 %
Regeneron Pharmaceuticals Inc   24.47 %
Vertex Pharmaceuticals Inc  24.34 %
Sunlink Health Systems Inc  24.22 %
Chemed Corporation  23.70 %
Mettler Toledo International Inc  23.18 %
Blueprint Medicines Corporation  22.74 %
Integrated Biopharma Inc  21.85 %
Infusystem Holdings Inc  20.93 %
Meridian Bioscience Inc   20.63 %
Seagen Inc   20.15 %
U s Neurosurgical Holdings Inc   19.65 %
Elite Pharmaceuticals Inc  18.46 %
Corcept Therapeutics Inc  18.44 %
Petmed Express Inc  18.09 %
Harrow Health Inc   17.46 %
Pro Dex Inc  17.23 %
Lifevantage Corp  16.96 %
Organogenesis Holdings Inc   16.42 %
Abiomed Inc   16.40 %
Apollo Medical Holdings Inc   16.18 %
West Pharmaceutical Services Inc   16.10 %
Voyager Therapeutics Inc   14.76 %
Emergent Biosolutions Inc   14.26 %
Incyte Corp  13.93 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

YTPG's Profile

Stock Price

YTPG's Financials

Business Description

Fundamentals

Charts & Quotes

YTPG's News

Suppliers

YTPG's Competitors

Customers & Markets

Economic Indicators

YTPG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071